TDP‐43 in amyotrophic lateral sclerosis: Pathophysiology or patho‐babel?
Author:
- 27 April 2007
- journal article
- Published by Wiley in Annals of Neurology
- Vol. 61 (5) , 382-384
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsAnnals of Neurology, 2007
- Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of dataThe Lancet Neurology, 2007
- TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutationActa Neuropathologica, 2007
- Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral SclerosisScience, 2006
- Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS ModelScience, 2003
- Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural TissuesNeurobiology of Disease, 2001
- Effect of recombinant human insulin-like growth factor-I on progression of ALSNeurology, 1997
- ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing InclusionsNeuron, 1997
- Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosisAnnals of Neurology, 1996
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994